Though most causes of a bounding pulse are reversible or treatable and not dangerous, in some cases, it may indicate a heart problem, like severe aortic regurgitation (heart valve disease), Keep in ...

Introduction: Aortic valve disease (AVD) is common among older adults. Although body mass index (BMI) has been reported to be a risk factor for aortic valve stenosis (AS), it is unknown whether BMI or ...

The aorta is widest at the point where it connects to the heart's left ventricle through the aortic valve; then, it gets progressively narrower as it descends into the abdomen. The aorta is divided ...

Hong Kong is the most competitive city in the Greater Bay Area in three of six critical industries, according to an index that compares the relative advantages of the southern Chinese region’s ...

about 4 hours ago NASDAQ Index, SP500, Dow Jones Forecasts – Dow Jones Gains Ground As Intel Soars 8.5%about 5 hours ago Natural Gas, WTI Oil, Brent Oil Forecasts – Oil Retreats As Traders ...

Aortic regurgitation occurs when blood leaks back into the left ventricle due to a leaky aortic valve. This is a type of valve disease in the heart. Aortic regurgitation can lead to some heart ...

The trial, whose results were published this week in The New England Journal of Medicine, could change the way doctors treat severe aortic stenosis, a narrowing of the valve that controls blood ...

Currently, there is a lack of evidence for the long‐term bioprosthetic valve durability of patients with bicuspid aortic valve (BAV) following transcatheter aortic valve replacement (TAVR).

The investigator-initiated, international, randomized controlled trial enrolled patients with NYHA class II-IV HFrEF (LV ejection fraction ≥20% and <50%) and moderate AS (aortic valve area >1.0 ...

More information: Philippe Généreux et al, Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis, New England Journal of Medicine (2024). DOI: 10.1056/NEJMoa2405880 ...

Additionally, patient hemodyanmics improved, with aortic valve area (AVA) increasing by 12% over baseline by six months post-procedure. “This clinical study is taking us one more step forward in ...

The company reported findings at Transcatheter Cardiovascular Therapeutics (TCT) 2024 in Washington, D.C. MitrAssist designed the Sikelia system for transcatheter aortic valve implantation (TAVI ...